Outreach medical care for housebound adults with Post-COVID syndrome or ME/CFS
Official title: OutreAch MediCal Care for HousEbound Patients With Post-COVID-19 Syndrome or ME/CFS of Any Cause
Run by Hannover Medical School · NCT07352254 · Data updated 2026-11-12
This project will try home visits and remote assessments to learn the symptoms and care needs of adults who are housebound with Post‑COVID syndrome or ME/CFS.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 69 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Hannover Medical School Academic / other |
| Locations | 1 site (Hanover) |
| Status | Recruiting |
| Started | January 2026 |
| Main results expected | October 2028 |
| Study ends | December 2028 |
| Registry record updated | January 21, 2026 |
| Trial ID | NCT07352254 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–70 who meet the Canadian Consensus Criteria for ME/CFS, have a Bell Score ≤30, and experience post‑exertional malaise lasting more than 14 hours are the intended participants.
✕Probably not a fit
People with pre‑existing conditions that limit mobility or mental capacity (for example major central nervous system diseases), those under 18 or over 70, or patients who can readily attend clinics are unlikely to benefit from this outreach program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The project deploys a multidisciplinary outreach program combining home visits and telemedicine to characterize clinical features and needs of housebound patients with Post‑COVID syndrome or ME/CFS. Specialists in internal medicine, neurology, and psychosomatic medicine will perform standardized histories, physical and mental assessments, and caregivers will be interviewed. Patients are recruited via primary care physicians, patient groups, social media, and post‑COVID outpatient clinics, and existing diagnostic data will be reviewed to identify mimics. The goal is to generate prevalence estimates and a structured care approach that could be integrated into routine services if effective.
Why it matters
Potential benefit: If successful, this could expand access to specialist diagnosis and tailored care for severely affected housebound patients and support routine implementation of outreach services.
How similar studies have gone: Home‑based assessments for other chronic conditions have shown benefit, but targeted outreach specifically for housebound Post‑COVID/ME/CFS patients is relatively novel and under‑studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ME/CFS according to the Canadian Consensus Criteria * Bell Score ≤ 30 * Duration of the postexertional malaise (PEM) \> 14 hours * Age \> 18 years and \< 70 Exclusion Criteria: \- Pre-existing conditions or comorbidities that have (or could have) led to a restriction of mobility or mental capacity, such as various diseases of the central nervous system.
Where it's running
-
Hannover Medical School
Hanover, Germany Recruiting
Study contacts
- Principal investigator: Meike Dirks, MD — Hannover Medical School
- Study coordinator: Meike Dirks, MD
- Email: access-patienten@mh-hannover.de
- Phone: +495115323145
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Whole-body Cryotherapy for Fatigue in ME/CFS, Fibromyalgia, Long COVID
This study tests whether brief, repeated exposure to extreme cold can help reduce fatigue and related symptoms in adults with ME/CFS, fibromyalgia, or Long COVID compared to healthy controls.
-
Hyperbaric Oxygen Therapy for ME/CFS
This study tests whether hyperbaric oxygen therapy can help people with mild to moderate ME/CFS.
-
Cognitive rehabilitation for ME/CFS brain fog
Researchers are testing two cognitive rehabilitation approaches to see which helps adults with ME/CFS and brain fog better manage thinking and daily tasks.
-
Improving life for patients with chronic fatigue syndrome
This study is testing if two medications can help people aged 18-65 with chronic fatigue syndrome feel better and manage their symptoms.
-
Using probiotics to treat Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
This study is testing if a new probiotic can help people aged 45 to 70 with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and possibly irritable bowel syndrome feel better.
-
Registry for ME/CFS patients in Germany
This study is creating a large registry to collect health information from people of all ages with ME/CFS in Germany, especially those affected by long-term COVID-19 effects, to help improve understanding and treatment of the condition.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.